Report Highlights
- The global market for nutraceutical products increased from $117.3 billion in 2007 to an estimated $123.9 billion in 2008. It should reach $176.7 billion in 2013, a compound annual growth rate (CAGR) of 7.4%.
- Nutraceutical foods currently have the largest share of the market and were worth $39.9 billion in 2007. This is expected to increase to $40.6 billion in 2008 and $56.7 billion in 2013, for a CAGR of 6.9%.
- Nutraceutical beverages generated $38.4 billion in 2007 and an estimated $42.8 billion in 2008. This segment is expected to dominate the market in 2013 with revenues of $71.3 billion, for a CAGR of 10.8%.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
- To define and measure the global market for nutraceuticals — the functional food, beverage, and supplement (FBS) market
- To measure markets that could be better understood by stakeholders in terms of their own respective sales offerings
- To strategically analyze individual markets in terms of products, ingredients, health applications, technology, geography, and top-selling products
- To identify trends and opportunities in the functional food, beverage, and supplement market for all stakeholders
- To provide quick and easy understanding of the very vast functional food, beverage, and supplement market
- To provide a strategic analysis of the market so as to enable companies to formulate their strategies
- To provide high-level analysis in terms of which products can sell in the mainstreams as blockbusters
Report Highlights
-
The global nutraceuticals market grew to $46.7 billion in 2002, at an AAGR of nearly 7%.
-
2007 nutraceutical sales are projected to reach $74.7 billion at an AAGR of 9.9%.
-
This assumes a world economic recovery in 2003 and an end to price competition.
-
Sales could accelerate with the introduction of a “blockbuster” nutraceutical.
Related Reports
Recent Reports
Probiotics in Food, Beverages, Dietary Supplements and Animal Feed
The global market for probiotics is expected to grow from $69.8 billion in 2024 and is projected to reach $102.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2024 to 2029.
Global Upcycled Food Market
This report presents the global upcycled food market, offering detailed insights into its current scenario and future potential. It includes market projections through 2029, and evaluates the market position of key players.
Nutraceuticals: Global Markets
The global market for nutraceuticals is expected to grow from $418.2 billion in 2024 and is projected to reach $571.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2024 to 2029.
Global Market for Coffee Machines
This comprehensive report explores the global coffee machine market, offering detailed insights into its current scenario and future potential. The analysis thoroughly examines market drivers, restraints, challenges, and opportunities, providing stakeholders with a holistic understanding of the industry dynamics.
The Global Market for Food Additives
The global market for food additives is expected to grow from $80.4 billion in 2024 and is projected to reach $106.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Top Trending Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Rare Disease Diagnostics: Technologies and Global Markets
The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.
Green Hydrogen: Global Markets
The global market for green hydrogen is expected to grow from $5.2 billion in 2024 and is projected to reach $38.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 48.7% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More